Literature DB >> 4840434

Chemical characterization of ethambutol binding to Mycobacterium smegmatis.

W H Beggs, F A Andrews.   

Abstract

Recent studies showed that critical binding of ethambutol to Mycobacterium smegmatis was both inhibited and reversed by ions. This apparent ion-susceptible characteristic suggested that ethambutol is held at critical sites by electrostatic bonds. Dissociation constant, pH, and ionic strength studies were designed to further characterize ethambutol binding. M. smegmatis was grown in Sauton synthetic liquid medium (pH 7.4) under aerated conditions at 37 C. The pH or ionic strength of the medium was modified to meet the needs of particular experiments. Titration data revealed that ethambutol dihydrochloride has two apparent dissociation constants (pKa(1) = 6.35, pKa(2) = 9.35). Uptake experiments, in which pH was varied, showed that dihydrochloride and free base ethambutol were bound to a greater extent than the monohydrochloride. However, dihydrochloride and free base binding were not related to biological activity. Ethambutol exerted its maximal growth inhibitory effect at pH values near neutrality, where it exists primarily as the monohydrochloride and showed minimal binding. The increased ethambutol binding observed at pH 7.4 in media of lowered ionic strength was consistent with growth studies showing a reduction in the minimal inhibitory growth concentration in such media. However, nonspecific as well as critical binding was enhanced at low ionic strength. We conclude that binding of ethambutol by M. smegmatis involves a heterogeneous group of drug binding sites, only one of which is directly related to biological activity. Although nothing is known about the ethambutol target site itself, critical binding of the drug seems to require the single positively charged monohydrochloride form. Both hydrogen bonds and ionic linkages are probably involved.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4840434      PMCID: PMC428954          DOI: 10.1128/AAC.5.3.234

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  THE SEQUENCE OF SOME EFFECTS OF STREPTOMYCIN IN ESCHERICHIA COLI.

Authors:  D T DUBIN; R HANCOCK; B D DAVIS
Journal:  Biochim Biophys Acta       Date:  1963-08-13

2.  Uptake of streptomycin by Escherichia coli.

Authors:  N ANAND; B D DAVIS; A K ARMITAGE
Journal:  Nature       Date:  1960-01-02       Impact factor: 49.962

3.  Primary binding of ethambutol by Mycobacterium smegmatis.

Authors:  W H Beggs; F A Andrews
Journal:  Am Rev Respir Dis       Date:  1973-10

4.  Uptake of ethambutol by Mycobacterium smegmatis and its relation to growth inhibition.

Authors:  W H Beggs; F A Andrews
Journal:  Am Rev Respir Dis       Date:  1973-09

5.  Mechanism for the pyridoxal neutralization of isoniazid action of Mycobacterium tuberculosis.

Authors:  W H Beggs; J W Jenne
Journal:  J Bacteriol       Date:  1967-10       Impact factor: 3.490

6.  Effect of ethambutol on Mycobacteria.

Authors:  M Forbes; E A Peets; N A Kuck
Journal:  Ann N Y Acad Sci       Date:  1966-04-20       Impact factor: 5.691

7.  Binding of dihydrostreptomycin to Escherichia coli ribosomes: characteristics and equilibrium of the reaction.

Authors:  F N Chang; J G Flaks
Journal:  Antimicrob Agents Chemother       Date:  1972-10       Impact factor: 5.191

8.  Mode of action of ethambutol.

Authors:  M FORBES; N A KUCK; E A PEETS
Journal:  J Bacteriol       Date:  1962-11       Impact factor: 3.490

  8 in total
  6 in total

1.  How to Predict the pK a of Any Compound in Any Solvent.

Authors:  Michael Busch; Ernst Ahlberg; Elisabet Ahlberg; Kari Laasonen
Journal:  ACS Omega       Date:  2022-05-09

2.  Metal binding by pharmaceuticals. Part 1. Copper(II) and zinc(II) interactions following ethambutol administration.

Authors:  A Cole; P M May; D R Williams
Journal:  Agents Actions       Date:  1981-05

3.  Inhibition of dihydrostreptomycin action on Mycobacterium smegmatis by monovalent and divalent cation salts.

Authors:  W H Beggs; F A Andrews
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

4.  Inhibition of dihydrostreptomycin binding to Mycobacterium smegmatis by monovalent and divalent cation salts.

Authors:  W H Beggs; F A Andrews
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

5.  Effects of ethambutol on accumulation and secretion of trehalose mycolates and free mycolic acid in Mycobacterium smegmatis.

Authors:  J O Kilburn; K Takayama
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

6.  Cryo-EM structure of arabinosyltransferase EmbB from Mycobacterium smegmatis.

Authors:  Yong Zi Tan; José Rodrigues; James E Keener; Ruixiang Blake Zheng; Richard Brunton; Brian Kloss; Sabrina I Giacometti; Ana L Rosário; Lei Zhang; Michael Niederweis; Oliver B Clarke; Todd L Lowary; Michael T Marty; Margarida Archer; Clinton S Potter; Bridget Carragher; Filippo Mancia
Journal:  Nat Commun       Date:  2020-07-07       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.